Ljubomir Jakovic
Overview
Explore the profile of Ljubomir Jakovic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
62
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jakovic L, Djordjevic V, Kraguljac Kurtovic N, Virijevic M, Mitrovic M, Trajkovic L, et al.
Medicina (Kaunas)
. 2024 Sep;
60(9).
PMID: 39336484
: With the advent of novel therapies for nucleophosmin gene ()-mutated acute myeloid leukemia (AML), there is a growing need for the reliable prediction of mutations. This study explored the...
2.
Pravdic Z, Suvajdzic-Vukovic N, Virijevic M, Mitrovic M, Pantic N, Sabljic N, et al.
J Med Biochem
. 2024 Aug;
43(4):545-555.
PMID: 39139169
Background: Cytarabine-anthracycline-based induction chemotherapy remains the standard of care for remission induction among patients with newly diagnosed acute myeloid leukaemia (AML). There are remarkable differences in therapy response among AML...
3.
Virijevic M, Kraguljac-Kurtovic N, Mitrovic M, Jakovic L, Bukumuric Z, Pantic N, et al.
Hematol Oncol
. 2024 Mar;
42(2):e3253.
PMID: 38536200
Examination of central nervous system (CNS) involvement is not routine diagnostic practice in adult patients with acute myeloid leukemia (AML). Therefore, many asymptomatic patients with CNS involvement might go undetected....
4.
Jakovic L, Jovanovic J, Kraguljac Kurtovic N, Dencic Fekete M, Bogdanovic A
Int J Lab Hematol
. 2024 Jan;
46(3):425-426.
PMID: 38243765
No abstract available.
5.
Jakovic L, Bogdanovic A, Djordjevic V, Dencic-Fekete M, Kraguljac-Kurtovic N, Knezevic V, et al.
Leuk Res
. 2018 Nov;
75:23-28.
PMID: 30445236
This study explores cytomorphologic features and their predictive role for early identification of acute myeloid leukemia (AML) with morphological distinctive recurrent cytogenetic abnormalities (RCA): t(15;17), t(8;21) and inv(16)/t(16;16). We retrospectively...
6.
Jakovic L, Gotic M, Gisslinger H, Soldatovic I, Sefer D, Tirnanic M, et al.
Ann Hematol
. 2018 May;
97(9):1581-1590.
PMID: 29717365
Regarding diagnosis of polycythemia vera (PV), discussion persists about hemoglobin (Hb) and/or hematocrit (Hct) threshold values as surrogate markers for red cell mass (RCM) and the diagnostic impact of bone...
7.
Colovic N, Lekovic D, Jakovic L
Srp Arh Celok Lek
. 2018 Apr;
144(7-8):450-5.
PMID: 29652459
No abstract available.
8.
Perunicic Jovanovic M, Mihaljevic B, Jakovic L, Martinovic V, Dencic Fekete M, Andjelic B, et al.
J BUON
. 2015 Jul;
20(3):820-8.
PMID: 26214636
Purpose: Despite major advances in the treatment of diffuse large B cell lymphoma (DLBCL), approximately one third of the patients progress or die, suggesting the existence of additional oncogenic events....
9.
Andjelic B, Antic D, Jakovic L, Todorovic M, Bogdanovic A, Djurasinovic V, et al.
Eur J Haematol
. 2014 May;
93(5):392-9.
PMID: 24797378
Based on the results of clinical trials, there is no global consensus on the optimal first-line therapy for patients with advanced Hodgkin lymphoma (HL) with both ABVD and BEACOPP currently...
10.
Bila J, Andjelic B, Bodrozic J, Jakovic L, Perunicic Jovanovic M, Vidovic A, et al.
Vojnosanit Pregl
. 2013 Dec;
70(10):972-5.
PMID: 24313182
Introduction: Special entities like solitary bone plasmocytoma (SBP) or extramedullary plasmacytoma (EMP) can be found in a less than 5% of patients with plasma cell disorders. EMP of the tongue...